Published November 14, 2008 | Version v1
Journal article

Icariin stimulates angiogenesis by activating the MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways in human endothelial cells

  • 1. Division of Food Biotechnology, School of Biotechnology, Kangwon National University, Chunchon, Kangwon-do (Korea, Republic of)
  • 2. Vascular System Research Center and Department of Molecular and Cellular Biochemistry, School of Medicine, Kangwon National University, Chunchon, Kangwon-do 200-701 (Korea, Republic of)
  • 3. Department of Anatomy, School of Medicine, Hallym University, Chunchon, Kangwon-do (Korea, Republic of)
  • 4. School of Life Sciences and Biotechnology, Korea University, 1, 5-Ka, Anam-dong, Sungbuk-ku, Seoul 136-701 (Korea, Republic of)
  • 5. Department of Biochemistry, College of Sciences, Yonsei University, Seoul (Korea, Republic of)

Description

We investigated the molecular effect and signal pathway of icariin, a major flavonoid of Epimedium koreanum Nakai, on angiogenesis. Icariin stimulated in vitro endothelial cell proliferation, migration, and tubulogenesis, which are typical phenomena of angiogenesis, as well as increased in vivo angiogenesis. Icariin activated the angiogenic signal modulators, ERK, phosphatidylinositol 3-kinase (PI3K), Akt, and endothelial nitric oxide synthase (eNOS), and increased NO production, without affecting VEGF expression, indicating that icariin may directly stimulate angiogenesis. Icariin-induced ERK activation and angiogenic events were significantly inhibited by the MEK inhibitor PD98059, without affecting Akt and eNOS phosphorylation. The PI3K inhibitor Wortmannin suppressed icariin-mediated angiogenesis and Akt and eNOS activation without affecting ERK phosphorylation. Moreover, the NOS inhibitor NMA partially reduced the angiogenic activity of icariin. These results suggest that icariin stimulated angiogenesis by activating the MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways and may be a useful drug for angiogenic therapy

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2008.09.001

Additional details

Identifiers

DOI
10.1016/j.bbrc.2008.09.001;
PII
S0006-291X(08)01736-1;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
376
Journal Issue
2
Journal Page Range
p. 404-408
ISSN
0006-291X
CODEN
BBRCA9

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
40085885
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
CELL PROLIFERATION; DRUGS; HUMAN POPULATIONS; IN VITRO; IN VIVO; NITRIC OXIDE; PHOSPHORYLATION; THERAPY; VEINS
Descriptors DEC
BLOOD VESSELS; BODY; CARDIOVASCULAR SYSTEM; CHALCOGENIDES; CHEMICAL REACTIONS; MEDICINE; NITROGEN COMPOUNDS; NITROGEN OXIDES; ORGANS; OXIDES; OXYGEN COMPOUNDS; POPULATIONS

Optional Information

Copyright
Copyright (c) 2008 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.